fbpx
October 4, 2022

Air Pollution Linked to Increased IBS Incidence Air Pollution Linked to Increased IBS Incidence

Increased levels of air pollution were linked to a slight uptick in new diagnoses of irritable bowel syndrome (IBS) in California residents, according to an ecologic […]
October 4, 2022

Long Sleep, Turning In Early May Up Risk for Dementia Long Sleep, Turning In Early May Up Risk for Dementia

Too much sleep and time in bed (TIB) may raise the risk of developing dementia and Alzheimer’s disease (AD), new research suggests. Results from a population-based […]
October 4, 2022

New Liver Stiffness Thresholds Refine NASH Risk Stratification New Liver Stiffness Thresholds Refine NASH Risk Stratification

New liver stiffness (LS) thresholds offer accurate prediction of disease progression and clinical outcomes in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis, according to investigators. […]
October 3, 2022

Moderna Refused China Request to Reveal Vaccine Technology Moderna Refused China Request to Reveal Vaccine Technology

(Reuters) – Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse […]
October 3, 2022

Amylyx Prices Newly Approved ALS Drug at $158,000 Per Year Amylyx Prices Newly Approved ALS Drug at $158,000 Per Year

(Reuters) – Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per […]
October 3, 2022

Will AI Affect the Burden of Surveillance After Polyp Removal? Will AI Affect the Burden of Surveillance After Polyp Removal?

While the use of artificial intelligence (AI) during colonoscopy may contribute to improved cancer prevention, it may also add to patient burden in terms of increased […]
October 3, 2022

FDA Approves Futibatinib for Certain Biliary Tract Cancers FDA Approves Futibatinib for Certain Biliary Tract Cancers

The US Food and Drug Administration (FDA) has granted an accelerated approval for a new drug, futibatinib (Lytgobi), to be used for patients with a certain […]
October 3, 2022

Ruxolitinib Repigments Many Vitiligo Affected Body Areas Ruxolitinib Repigments Many Vitiligo Affected Body Areas

Ruxolitinib (Opzelura) cream can help repigment the skin in many body areas affected with vitiligo, researchers reported at the European Academy of Dermatology and Venereology (EADV) […]
October 3, 2022

Gardasil 9 HPV Vaccine Advised for MSM Living With HIV Gardasil 9 HPV Vaccine Advised for MSM Living With HIV

Men who have sex with men (MSM) living with HIV, especially those who are young or who’ve had gonorrhea should get the human papillomavirus (HPV) 9-valent […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0